How a single independent review is reshaping NHS gender identity services
In short: In April 2024, the final report of the Cass Review was published, triggering a massive overhaul of UK pediatric care. From closing established clinics to banning certain hormone prescriptions, the recommendations are fundamentally changing how the NHS approaches gender-related distress for young people.
Commissioned by NHS England in 202 and led by Dr. Hilary Cass, a retired consultant pediatrician, the review investigated gender identity services for children and young people. The findings highlighted a critical lack of evidence regarding the safety, risks, and benefits of medical interventions. Consequently, a new national clinical policy was adopted, preventing the prescribing of puberty suppressing hormones to anyone under 18 experiencing gender dysphoria, except within the context of clinical trials. This policy change follows concerns raised by several GIDS staff members regarding the strength of the evidence base for treatments. To address these gaps, a National Research Oversight Board, including the National Institute for Health and Care Research, will now guide a comprehensive research programme.
The impact on existing infrastructure has been significant. In the early months of 2024, the Tavistock and Portman NHS Foundation Trust's Gender Identity Development Service (GIDS) underwent a controlled shutdown. In its place, new regional services began operating in London and the North West as of April 2024. The long-term vision involves expanding to a network of eight regional centers, with further services planned for the South West and East of England. The expansion is part of a structured two-year action plan. While the North West and London services are already operational, the South West regional service is scheduled for development between August and October 2024.
The new model of care emphasizes a psychosocial and psychological approach rather than a purely medical one. This includes a more cautious approach to assessment and social transition for younger children. To manage the transition, NHS England implemented a new referral pathway on 1 September 2024, requiring all new referrals to come through NHS secondary care services, such as mental health or pediatric teams, to ensure thorough assessments of need. To support this new clinical landscape, the Academy of Medical Royal Colleges has been commissioned to provide induction training for new staff. Additionally, a Multi-Disciplinary Team with an independent chair will now be responsible for reviewing all referrals for gender-affirming hormones.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: NHS England » Children and young people’s gender services: implementing the Cass Review recommendations
- Also: Cass Review
To cite this card, link to https://intellectplus.co.uk/app/health-cass-review.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Psychiatry · More in Health · Latest · A–Z · All topics
